National Cancer Institute; Amended Notice of Meeting, 11423 [08-908]
Download as PDF
<![CDATA[
rmajette on PROD1PC64 with NOTICES
Federal Register / Vol. 73, No. 42 / Monday, March 3, 2008 / Notices
Executive Blvd., Room 8053, Bethesda, MD
20892, 301/435–1822, githenss@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Antibody
Array for Cancer Detection.
Date: March 26–27, 2008.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Sherwood Githens, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Blvd., Room 8053, Bethesda, MD
20892, 301/435–1822, githenss@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Cancer
Stem Cells.
Date: March 27, 2008.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Irina Gordienko, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Room 7073, Bethesda,
MD 20892, 301–594–1566,
gordienkoiv@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Portable
Energy Balance Review Panel (PEBRP).
Date: April 2, 2008.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: C. Michael Kerwin, PhD,
MPH, Scientific Review Officer, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd., Rm.
8057, Bethesda, MD 20892–8329, 301–496–
7421, kerwinm@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, A webbased tailored health behavior intervention
for African American colon cancer.
Date: April 2, 2008.
Open: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: C. Michael Kerwin, PhD,
MPH, Scientific Review Officer, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd., Rm.
8057, Bethesda, MD 20892–8329, 301–496–
7421, kerwinm@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel,
Development of Clinical Mass Spectrometric
Immunoassays.
Date: April 3, 2008.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
VerDate Aug<31>2005
15:33 Feb 29, 2008
Jkt 214001
Place: National Institutes of Health, 6116
Executive Boulevard, CR 6008, Rockville, MD
20852 (Telephone Conference Call).
Contact Person: Sherwood Githens, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Blvd., Room 8053, Bethesda, MD
20892, 301/435–1822, githenss@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Network
for Translational Research: Optical Imaging
(NTROI).
Date: June 2–3, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington DC North—
Gaithersburg, 620 Perry Parkway,
Gaithersburg, MD 20877.
Contact Person: Kenneth L. Bielat, PhD,
Scientific Review Officer, Special Review
Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 7147, Bethesda,
MD 20892–8329, 301–496–7576,
bielatk@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Cancer
Prevention Research.
Date: June 17–18, 2008.
Time: 7 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance M Street Hotel, 1143
New Hampshire Avenue, NW., Washington,
DC 20037.
Contact Person: Irina Gordienko, PhD,
Scientific Review Officer, Scientific Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6166 Executive Blvd., Rm. 7073, Bethesda,
MD 20892, 301–594–1566,
gordienkoiv@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 21, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–906 Filed 2–29–08: 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, April
7, 2008, 8 a.m. to April 7, 5 p.m.,
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
11423
Gaithersburg Hilton, 620 Perry Parkway,
Gaithersburg, MD, 20877 which was
published in the Federal Register on
February 15, 2008, 73FR8886–8887.
This notice is amended to change the
name from ‘‘Biosensors for Early Cancer
Detection & Risk Assessment/Novel &
Improved Methods to Measure Cancer
Epigenetic Biomarkers’’ to ‘‘Biosensors/
Cancer Epigenetic Biomarkers’’. The
meeting is closed to the public.
Dated: February 25, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–908 Filed 2–29–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of
Closing Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
mended (5 U.S.C. Appendix 2), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended.
The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel, NEI Cooperative
Agreement Review.
Date: March 6, 2008.
Time: 9 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Houmam H. Araj, PHD,
Scientific Review Administrator, Division of
Extramural Research, National Eye Institute,
NIH, 5635 Fishers Lane, Suite 1300,
Bethesda, MD 20892–9602, 301–451–2020,
Haraj@mail.nih.gov.
This notice is being published less than 15
days prior to the meetings due to the timing
limitations impose by the review and funding
cycle.
Name of Committee: National Eye Institute
Special Emphasis Panel, NEI Cooperative
Agreement Review.
Date: March 20, 2008.
Time: 12 p.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\03MRN1.SGM
03MRN1
]]>Agencies
[Federal Register Volume 73, Number 42 (Monday, March 3, 2008)]
[Notices]
[Page 11423]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 08-908]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Institute Special Emphasis Panel, April 7, 2008, 8 a.m. to April
7, 5 p.m., Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD,
20877 which was published in the Federal Register on February 15, 2008,
73FR8886-8887.
This notice is amended to change the name from ``Biosensors for
Early Cancer Detection & Risk Assessment/Novel & Improved Methods to
Measure Cancer Epigenetic Biomarkers'' to ``Biosensors/Cancer
Epigenetic Biomarkers''. The meeting is closed to the public.
Dated: February 25, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-908 Filed 2-29-08; 8:45 am]
BILLING CODE 4140-01-M[FEDREG][VOL]*[/VOL][NO]*[/NO][DATE]*[/
DATE][NOTICES]
